Total Holdings
65
Portfolio diversification across 65 positions
HELX
(BATS)Franklin Genomic Advancements ETF
$43.51-- (--)
Loading... - Market loading
HELX ETF Holdings: Franklin Genomic Advancements ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$29.13M
Total fund assets
Expense Ratio
0.50%
Annual management fee
Fund Issuer
Franklin Templeton
BATS
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 50 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Guardant Health, Inc | Stock | 9.54% |
| 2 |  | Natera, Inc | Stock | 7.53% |
| 3 |  | Krystal Biotech, Inc | Stock | 5.91% |
| 4 |  | Ligand Pharmaceuticals Incorporated | Stock | 4.52% |
| 5 |  | Adaptive Biotechnologies Corporation | Stock | 4.25% |
| 6 |  | BridgeBio Pharma, Inc. | Stock | 3.99% |
| 7 |  | United Therapeutics Corporation | Stock | 3.51% |
| 8 |  | Eli Lilly and Company | Stock | 2.99% |
| 9 |  | Vertex Pharmaceuticals Incorporated | Stock | 2.73% |
| 10 |  | Travere Therapeutics, Inc. | Stock | 2.65% |
| 11 |  | Twist Bioscience Corporation | Stock | 2.62% |
| 12 |  | Insmed Incorporated | Stock | 2.51% |
| 13 |  | Medpace Holdings, Inc. | Stock | 2.51% |
| 14 | L LON:AZN | AstraZeneca PLC | Stock | 2.45% |
| 15 | L LSE:AZN | AstraZeneca PLC | Stock | 2.45% |
| 16 | K KRX:207940 | Samsung Biologics Co.,Ltd. | Stock | 2.42% |
| 17 |  | Corteva, Inc. | Stock | 2.42% |
| 18 | K KO:207940 | Samsung Biologics Co Ltd | Stock | 2.41% |
| 19 |  | Regeneron Pharmaceuticals, Inc | Stock | 1.99% |
| 20 |  | Neurocrine Biosciences, Inc. | Stock | 1.95% |
| 21 |  | Alnylam Pharmaceuticals, Inc | Stock | 1.87% |
| 22 |  | Tempus AI, Inc. Class A Common Stock | Stock | 1.83% |
| 23 |  | Veracyte, Inc | Stock | 1.68% |
| 24 | E EBR:ARGX | argenx SE | Stock | 1.64% |
| 25 |  | PTC Therapeutics, Inc. | Stock | 1.44% |
| 26 |  | BioNTech SE | Stock | 1.40% |
| 27 |  | Ionis Pharmaceuticals, Inc | Stock | 1.34% |
| 28 |  | Charles River Laboratories International, Inc | Stock | 1.30% |
| 29 |  | Stoke Therapeutics, Inc | Stock | 1.20% |
| 30 |  | CareDx, Inc | Stock | 1.17% |
| 31 |  | GRAIL, LLC | Stock | 1.17% |
| 32 |  | Repligen Corporation | Stock | 1.08% |
| 33 |  | Cadence Design Systems, Inc | Stock | 0.96% |
| 34 | E ETR:SRT3 | Sartorius Aktiengesellschaft | Stock | 0.93% |
| 35 |  | CRISPR Therapeutics AG | Stock | 0.89% |
| 36 |  | AnaptysBio, Inc | Stock | 0.84% |
| 37 |  | Thermo Fisher Scientific Inc | Stock | 0.83% |
| 38 |  | IQVIA Holdings Inc | Stock | 0.83% |
| 39 |  | Axsome Therapeutics, Inc | Stock | 0.81% |
| 40 |  | Praxis Precision Medicines, Inc | Stock | 0.80% |
| 41 |  | Jazz Pharmaceuticals plc | Stock | 0.80% |
| 42 |  | Beam Therapeutics Inc | Stock | 0.78% |
| 43 |  | Hinge Health, Inc. | Stock | 0.73% |
| 44 |  | Danaher Corporation | Stock | 0.63% |
| 45 |  | Agilent Technologies, Inc | Stock | 0.60% |
| 46 |  | Ultragenyx Pharmaceutical Inc | Stock | 0.56% |
| 47 | E ETR:QIA | QIAGEN N.V | Stock | 0.52% |
| 48 |  | Arcutis Biotherapeutics, Inc | Stock | 0.45% |
| 49 |  | Rhythm Pharmaceuticals, Inc | Stock | 0.40% |
| 50 |  | First Tracks Biotherapeutics | Stock | 0.37% |
Frequently Asked Questions About Franklin Genomic Advancements ETF Holdings
What are the top holdings in HELX?
Franklin Genomic Advancements ETF (HELX) holds 65 securities. View the complete list of top holdings sorted by portfolio weight, showing each security's ticker symbol, company name, asset type, and allocation percentage.
How concentrated is HELX's portfolio?
Portfolio concentration is measured by the weight of top holdings. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly. Review HELX's holdings table to analyze concentration risk.
What is HELX's sector allocation?
The Sector Allocation chart shows how HELX distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does HELX invest in?
HELX's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is HELX ETF?
HELX's diversification can be assessed by reviewing its 65 holdings, sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.